A novel technology to integrate imaging and clinical markers for non-invasive diagnosis of lung cancer
Open Access
- 25 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-10
- https://doi.org/10.1038/s41598-021-83907-5
Abstract
This study presents a non-invasive, automated, clinical diagnostic system for early diagnosis of lung cancer that integrates imaging data from a single computed tomography scan and breath bio-markers obtained from a single exhaled breath to quickly and accurately classify lung nodules. CT imaging and breath volatile organic compounds data were collected from 47 patients. Spherical Harmonics-based shape features to quantify the shape complexity of the pulmonary nodules, 7th-Order Markov Gibbs Random Field based appearance model to describe the spatial non-homogeneities in the pulmonary nodule, and volumetric features (size) of pulmonary nodules were calculated from CT images. 27 VOCs in exhaled breath were captured by a micro-reactor approach and quantied using mass spectrometry. CT and breath markers were input into a deep-learning autoencoder classifier with a leave-one-subject-out cross validation for nodule classification. To mitigate the limitation of a small sample size and validate the methodology for individual markers, retrospective CT scans from 467 patients with 727 pulmonary nodules, and breath samples from 504 patients were analyzed. The CAD system achieved 97.8% accuracy, 97.3% sensitivity, 100% specificity, and 99.1% area under curve in classifying pulmonary nodules.This publication has 33 references indexed in Scilit:
- Early diagnosis of lung cancerF1000Prime Reports, 2013
- Automatic Detection of 2D and 3D Lung Nodules in Chest Spiral CT ScansInternational Journal of Biomedical Imaging, 2013
- Computer-Aided Diagnosis Systems for Lung Cancer: Challenges and MethodologiesInternational Journal of Biomedical Imaging, 2013
- Urinary Volatile Compounds as Biomarkers for Lung CancerBioscience, Biotechnology, and Biochemistry, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNAClinical Cancer Research, 2011
- Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.Journal of Hematology & Oncology, 2008
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung CancerClinical Cancer Research, 2007
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningThe New England Journal of Medicine, 2006